Association between beta cell function and future glycemic control in patients with type 2 diabetes

Yoshifumi Saisho, Kinsei Kou, Kumiko Tanaka, Takayuki Abe, Akira Shimada, Toshihide Kawai, Hiroshi Itoh

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The aim of this study was to clarify the association between C-peptide immunoreactivity (CPR), a marker of beta cell function, and future glycemic control in patients with type 2 diabetes. We conducted a retrospective analysis of 513 consecutive patients with type 2 diabetes who were admitted to our hospital between 2000 and 2007 and followed up for 2 years. Serum and urinary CPR levels were measured during admission, and CPR index was calculated as the ratio of CPR to plasma glucose. The associations between these markers at baseline and glycemic control after 2 years were assessed by means of logistic regression models. After 2 years, 167 patients (32.6%) showed good glycemic control (HbA1c <6.9%). Baseline serum and urinary CPR indices were significantly associated with good glycemic control after 2 years, and the postprandial CPR to plasma glucose ratio (postprandial CPR index) showed the strongest association (odds ratio (OR) 1.29, 95% confidence interval (CI) 1.12-1.50, P = 0.001) among CPR indices. Multivariate analyses showed consistent results (OR 1.23, 95%CI 1.03-1.48, P = 0.021). In conclusion, preserved beta cell function at baseline was associated with better glycemic control thereafter in patients with type 2 diabetes.

Original languageEnglish
Pages (from-to)517-523
Number of pages7
JournalEndocrine Journal
Volume60
Issue number4
Publication statusPublished - 2013

Fingerprint

C-Peptide
Type 2 Diabetes Mellitus
Logistic Models
Odds Ratio
Confidence Intervals
Glucose
Serum
Multivariate Analysis

Keywords

  • Beta cell function
  • C-peptide
  • Glycated hemoglobin
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Association between beta cell function and future glycemic control in patients with type 2 diabetes. / Saisho, Yoshifumi; Kou, Kinsei; Tanaka, Kumiko; Abe, Takayuki; Shimada, Akira; Kawai, Toshihide; Itoh, Hiroshi.

In: Endocrine Journal, Vol. 60, No. 4, 2013, p. 517-523.

Research output: Contribution to journalArticle

Saisho, Y, Kou, K, Tanaka, K, Abe, T, Shimada, A, Kawai, T & Itoh, H 2013, 'Association between beta cell function and future glycemic control in patients with type 2 diabetes', Endocrine Journal, vol. 60, no. 4, pp. 517-523.
Saisho, Yoshifumi ; Kou, Kinsei ; Tanaka, Kumiko ; Abe, Takayuki ; Shimada, Akira ; Kawai, Toshihide ; Itoh, Hiroshi. / Association between beta cell function and future glycemic control in patients with type 2 diabetes. In: Endocrine Journal. 2013 ; Vol. 60, No. 4. pp. 517-523.
@article{f076f89660ef4901ac3f9fd69656b333,
title = "Association between beta cell function and future glycemic control in patients with type 2 diabetes",
abstract = "The aim of this study was to clarify the association between C-peptide immunoreactivity (CPR), a marker of beta cell function, and future glycemic control in patients with type 2 diabetes. We conducted a retrospective analysis of 513 consecutive patients with type 2 diabetes who were admitted to our hospital between 2000 and 2007 and followed up for 2 years. Serum and urinary CPR levels were measured during admission, and CPR index was calculated as the ratio of CPR to plasma glucose. The associations between these markers at baseline and glycemic control after 2 years were assessed by means of logistic regression models. After 2 years, 167 patients (32.6{\%}) showed good glycemic control (HbA1c <6.9{\%}). Baseline serum and urinary CPR indices were significantly associated with good glycemic control after 2 years, and the postprandial CPR to plasma glucose ratio (postprandial CPR index) showed the strongest association (odds ratio (OR) 1.29, 95{\%} confidence interval (CI) 1.12-1.50, P = 0.001) among CPR indices. Multivariate analyses showed consistent results (OR 1.23, 95{\%}CI 1.03-1.48, P = 0.021). In conclusion, preserved beta cell function at baseline was associated with better glycemic control thereafter in patients with type 2 diabetes.",
keywords = "Beta cell function, C-peptide, Glycated hemoglobin, Type 2 diabetes",
author = "Yoshifumi Saisho and Kinsei Kou and Kumiko Tanaka and Takayuki Abe and Akira Shimada and Toshihide Kawai and Hiroshi Itoh",
year = "2013",
language = "English",
volume = "60",
pages = "517--523",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Association between beta cell function and future glycemic control in patients with type 2 diabetes

AU - Saisho, Yoshifumi

AU - Kou, Kinsei

AU - Tanaka, Kumiko

AU - Abe, Takayuki

AU - Shimada, Akira

AU - Kawai, Toshihide

AU - Itoh, Hiroshi

PY - 2013

Y1 - 2013

N2 - The aim of this study was to clarify the association between C-peptide immunoreactivity (CPR), a marker of beta cell function, and future glycemic control in patients with type 2 diabetes. We conducted a retrospective analysis of 513 consecutive patients with type 2 diabetes who were admitted to our hospital between 2000 and 2007 and followed up for 2 years. Serum and urinary CPR levels were measured during admission, and CPR index was calculated as the ratio of CPR to plasma glucose. The associations between these markers at baseline and glycemic control after 2 years were assessed by means of logistic regression models. After 2 years, 167 patients (32.6%) showed good glycemic control (HbA1c <6.9%). Baseline serum and urinary CPR indices were significantly associated with good glycemic control after 2 years, and the postprandial CPR to plasma glucose ratio (postprandial CPR index) showed the strongest association (odds ratio (OR) 1.29, 95% confidence interval (CI) 1.12-1.50, P = 0.001) among CPR indices. Multivariate analyses showed consistent results (OR 1.23, 95%CI 1.03-1.48, P = 0.021). In conclusion, preserved beta cell function at baseline was associated with better glycemic control thereafter in patients with type 2 diabetes.

AB - The aim of this study was to clarify the association between C-peptide immunoreactivity (CPR), a marker of beta cell function, and future glycemic control in patients with type 2 diabetes. We conducted a retrospective analysis of 513 consecutive patients with type 2 diabetes who were admitted to our hospital between 2000 and 2007 and followed up for 2 years. Serum and urinary CPR levels were measured during admission, and CPR index was calculated as the ratio of CPR to plasma glucose. The associations between these markers at baseline and glycemic control after 2 years were assessed by means of logistic regression models. After 2 years, 167 patients (32.6%) showed good glycemic control (HbA1c <6.9%). Baseline serum and urinary CPR indices were significantly associated with good glycemic control after 2 years, and the postprandial CPR to plasma glucose ratio (postprandial CPR index) showed the strongest association (odds ratio (OR) 1.29, 95% confidence interval (CI) 1.12-1.50, P = 0.001) among CPR indices. Multivariate analyses showed consistent results (OR 1.23, 95%CI 1.03-1.48, P = 0.021). In conclusion, preserved beta cell function at baseline was associated with better glycemic control thereafter in patients with type 2 diabetes.

KW - Beta cell function

KW - C-peptide

KW - Glycated hemoglobin

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84876979820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876979820&partnerID=8YFLogxK

M3 - Article

C2 - 23268927

AN - SCOPUS:84876979820

VL - 60

SP - 517

EP - 523

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 4

ER -